nicardipine has been researched along with Infant, Newborn, Diseases in 1 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicardipine is a desirable option because of its rapid and titratable antihypertensive properties and low incidence of adverse effects." | 1.51 | Nicardipine for the Treatment of Neonatal Hypertension During Extracorporeal Membrane Oxygenation. ( DeAvilla, KM; Liviskie, CJ; McPherson, CC; Najaf, T; Zeller, BN, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liviskie, CJ | 1 |
| DeAvilla, KM | 1 |
| Zeller, BN | 1 |
| Najaf, T | 1 |
| McPherson, CC | 1 |
1 other study available for nicardipine and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Nicardipine for the Treatment of Neonatal Hypertension During Extracorporeal Membrane Oxygenation.
Topics: Antihypertensive Agents; Blood Pressure; Essential Hypertension; Extracorporeal Membrane Oxygenation | 2019 |